Artigo · Revista · 2010

Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months

Ramadhani A Noor, Michael Thiesen, Benjamin Mordmüller, Paul Milligan, Frank Atuguba, Sodiomon B. Sirima e mais 9

Malaria Journal

• Acesso aberto · Dourado
• Internacional · 9 países

Lê-lo10.1186/1475-2875-9-s2-p26